公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2022 | Correction to: The Difference in Clinical Outcomes Between Osimertinib and Afatinib for First-Line Treatment in Patients with Advanced and Recurrent EGFR-Mutant Non-Small Cell Lung Cancer in Taiwan | Huang, Yen-Hsiang; Hsu, Kuo-Hsuan; Tseng, Jeng-Sen; Yang, Tsung-Ying; Chen, Kun-Chieh; KANG-YI SU ; SUNG-LIANG YU ; Chen, Jeremy J W; Chang, Gee-Chen | Targeted oncology | 0 | 0 | |
1994 | Correlates and predictive models for blood pressure values in residents of two communities in Taiwan. | Pan W.H.; Chen Y.C.; SUNG-LIANG YU ; Sun J.A.; Chang Y.S.; Chen C.J. | Journal of the Formosan Medical Association = Taiwan yi zhi | 6 | 0 | |
2017 | Crosstalk between CLCb/Dyn1-Mediated Adaptive Clathrin-Mediated Endocytosis and Epidermal Growth Factor Receptor Signaling Increases Metastasis | PING-HUNG CHEN ; Bendris N.; Hsiao Y.-J.; Reis C.R.; Mettlen M.; Chen H.-Y.; SUNG-LIANG YU ; Schmid S.L. | Developmental Cell | 62 | 61 | |
2011 | Curcumin induces EGFR degradation in lung adenocarcinoma and modulates p38 activation in intestine: The versatile adjuvant for gefitinib therapy | Lee J.-Y.; Lee Y.-M.; Chang G.-C.; SUNG-LIANG YU ; Hsieh W.-Y.; Chen J.J.W.; HUEI-WEN CHEN ; PAN-CHYR YANG | PLoS ONE | 111 | 86 | |
2008 | Curcumin inhibits lung cancer cell invasion and metastasis through the tumor suppressor HLJ1 | HUEI-WEN CHEN ; Lee J.-Y.; Huang J.-Y.; Wang C.-C.; Chen W.-J.; SHENG-FANG SU ; Huang C.-W.; CHAO-CHI HO ; Chen J.J.W.; Tsai M.-F.; SUNG-LIANG YU ; PAN-CHYR YANG | Cancer Research | 210 | 194 | |
2013 | Curcumin suppresses metastasis via Sp-1, FAK inhibition, and E-cadherin upregulation in colorectal cancer | Chen C.-C.; Sureshbabul M.; HUEI-WEN CHEN ; Lin Y.-S.; Lee J.-Y.; Hong Q.-S.; YA-CHIEN YANG ; SUNG-LIANG YU | Evidence-based Complementary and Alternative Medicine | 71 | 44 | |
2002 | Cyclosporine A regulate oxidative stress-induced apoptosis in cardiomyocytes: Mechanisms via ROS generation, iNOS and Hsp70 | HUEI-WEN CHEN ; Chien C.-T.; SUNG-LIANG YU ; Lee Y.-T.; WEN-JONE CHEN | British Journal of Pharmacology | 98 | 88 | |
2012 | Development of novel antibacterial agents against methicillin-resistant Staphylococcus aureus | HAO-CHIEH CHIU ; Lee S.-L.; Kapuriya N.; Wang D.; Chen Y.-R.; SUNG-LIANG YU ; Kulp S.K.; LEE-JENE TENG ; Chen C.-S. | Bioorganic and Medicinal Chemistry | 35 | 29 | |
2022 | The Difference in Clinical Outcomes Between Osimertinib and Afatinib for First-Line Treatment in Patients with Advanced and Recurrent EGFR-Mutant Non-Small Cell Lung Cancer in Taiwan | Huang, Yen-Hsiang; Hsu, Kuo-Hsuan; Tseng, Jeng-Sen; Yang, Tsung-Ying; Chen, Kun-Chieh; KANG-YI SU ; SUNG-LIANG YU ; Chen, Jeremy J W; Chang, Gee-Chen | Targeted oncology | 7 | 7 | |
2004 | Differential gene expression in gram-negative and gram-positive sepsis | SUNG-LIANG YU ; HUEI-WEN CHEN ; PAN-CHYR YANG ; Peck K.; Tsai M.-H.; Chen J.J.W.; Lin F.-Y. | American Journal of Respiratory and Critical Care Medicine | 69 | 55 | |
2015 | DNA Hypermethylation of SHISA3 in Colorectal Cancer: An Independent Predictor of Poor Prognosis | Tsai, Ming-Hong; Chen, Wen-Chi; SUNG-LIANG YU ; Chen, Chun-Chieh; TZU-MING JAO ; Huang, Chi-Yen; Tzeng, Sheng-Tai; Yen, Sou-Jhy; YA-CHIEN YANG | Annals of Surgical Oncology | 20 | 18 | |
2014 | Do interleukin-10 and superoxide ions predict outcomes of cardiac extracorporeal membrane oxygenation patients? | Hong, Tsai-Hsia; SHUENN-WEN KUO ; Hu, Fu-Chang; Ko, Wen-Je; LI-MIN HSU ; SHU-CHIEN HUANG ; YA-WEN YANG ; SUNG-LIANG YU ; YIH-SHARNG CHEN | Antioxidants & redox signaling | 16 | 12 | |
2015 | A double negative loop comprising ETV6/RUNX1 and MIR181A1 contributes to differentiation block in t(12;21)-positive acute lymphoblastic leukemia | YUNG-LI YANG ; Yen C.-T.; Pai C.-H.; Chen H.-Y.; SUNG-LIANG YU ; Lin C.-Y.; CHUNG-YI HU ; SHIANN-TANG JOU ; Lin D.-T.; Lin S.-R.; SHU-WHA LIN | PLoS ONE | 14 | 12 | |
2004 | Dynamic changes of gene expression profiles during postnatal development of the heart in mice | HUEI-WEN CHEN ; SUNG-LIANG YU ; WEN-JONE CHEN ; PAN-CHYR YANG ; Chien C.-T.; HAN-YI E. CHOU ; Li H.-N.; Peck K.; CHIEN-HUA HUANG ; Lin F.-Y.; Chen J.J.W.; Lee Y.-T. | Heart | 41 | 38 | |
2015 | Dynamic plasma EGFR mutation status as a predictor of EGFR-TKI efficacy in patients with EGFR-mutant lung adenocarcinoma | Tseng, Jeng-Sen; Yang, Tsung-Ying; Tsai, Chi-Ren; Chen, Kun-Chieh; Hsu, Kuo-Hsuan; Tsai, Meen-Hsin; SUNG-LIANG YU ; KANG-YI SU ; Chen, Jeremy J. W.; MONG-HSUN TSAI | Journal of Thoracic Oncology | 63 | 61 | |
2019 | Editor's Note: MicroRNA-519c Suppresses Hypoxia-Inducible Factor-1α Expression and Tumor Angiogenesis | Cha, Shih-Ting; Chen, Pai-Sheng; Johansson, Gunnar; CHIA-YU CHU ; Wang, Ming-Yang; YUNG-MING JENG ; SUNG-LIANG YU ; JIN-SHING CHEN ; KING-JEN CHANG ; Jee, Shiou-Hwa; CHING-TING TAN ; MING-TSAN LIN ; Kuo, Min-Liang | Cancer research | 1 | 1 | |
2015 | EGFR mutation and lobar location of lung adenocarcinoma | Tseng C.-H.; Chen K.-C.; Hsu K.-H.; Tseng J.-S.; CHAO-CHI HO ; Hsia T.-C.; KANG-YI SU ; Wu M.-F.; Chiu K.-L.; Liu C.-M.; Wu T.-C.; Chen H.-J.; Chen H.-Y.; Chang C.-S.; Hsu C.-P.; Hsia J.-Y.; Chuang C.-Y.; Lin C.-H.; Chen J.J.W.; KUAN-YU CHEN ; WEI-YU LIAO ; JIN-YUAN SHIH ; SUNG-LIANG YU ; CHONG-JEN YU ; PAN-CHYR YANG ; Yang T.-Y.; Chang G.-C. | Carcinogenesis | 13 | 12 | |
2017 | EGFR mutation, smoking, and gender in advanced lung adenocarcinoma | Tseng, Chien-Hua; CHUN-JU CHIANG ; Tseng, Jeng-Sen; Yang, Tsung-Ying; Hsu, Kuo-Hsuan; Chen, Kun-Chieh; Wang, Chih-Liang; Chen, Chih-Yi; Yen, Sang-Hue; Tsai, Chun-Ming; Huang, Ming-Shyan; CHAO-CHI HO ; CHONG-JEN YU ; Tsai, Ying-Huang; JIN-SHING CHEN ; Chou, Teh-Ying; Tsai, Ming-Hsun; Chen, Hsuan-Yu; KANG-YI SU ; Chen, Jeremy J. W.; HUEI-WEN CHEN ; SUNG-LIANG YU ; Liu, Tsang-Wu; MONG-HSUN TSAI | Oncotarget | 54 | 41 | |
2016 | EGFR-activating mutations, DNA copy number abundance of ErbB family, and prognosis in lung adenocarcinoma | Chen H.-Y.; Liu C.-H.; Chang Y.-H.; SUNG-LIANG YU ; Ho B.C.; Hsu C.-P.; Yang T.-Y.; Chen K.-C.; Hsu K.-H.; Tseng J.-S.; Hsia J.-Y.; Chuang C.-Y.; Chang C.-S.; Li Y.-C.; Li K.-C.; Chang G.-C.; PAN-CHYR YANG | Oncotarget | 14 | 16 | |
2019 | EGFR-Mutant SCLC Exhibits Heterogeneous Phenotypes and Resistance to Common Antineoplastic Drugs | Lin C.-A.; SUNG-LIANG YU ; Chen H.-Y.; HUEI-WEN CHEN ; Lin S.-U.; Chang C.-C.; CHONG-JEN YU ; PAN-CHYR YANG ; CHAO-CHI HO | Journal of Thoracic Oncology | 13 | 10 | |